1-27 of 27
Keywords: biomarker
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Clin Sci (Lond) (2022) 136 (12): 953–971.
Published: 22 June 2022
.... 09 03 2022 05 05 2022 09 05 2022 09 05 2022 © 2022 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2022 biomarker circUSP36 ischemic stroke miR-139-3p SMAD3 Stroke is a common neurological disease, the second leading...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2020) 134 (20): 2741–2754.
Published: 28 October 2020
... 2020 biomarker extracellular vesicles glomerular diseases mechanism therapy Extracellular vesicles (EVs), including exosomes, microvesicles and apoptotic bodies [ 1 ], are membrane-bound nanoparticles released by most cells and can be detected in diverse biological fluids [ 2 ]. First...
Articles
Clin Sci (Lond) (2018) 132 (21): 2285–2298.
Published: 02 November 2018
... be reversed by down-regulation of DNMT1. Hsa_circ_0012919 regulated KLF13 and RANTES by miR-125a . Conclusion: Hsa_circ_0012919 could be regarded as a biomarker for SLE and hsa_circ_0012919 was the competitive endogenous RNA (ceRNA) for miR-125a-3p . Correspondence: Chao Zhang ( charleszhang1980@126.com...
Articles
Clin Sci (Lond) (2018) 132 (14): 1565–1580.
Published: 31 July 2018
... actin (αSMA)-positive myofibroblasts is important in the progression of idiopathic pulmonary fibrosis (IPF), few biomarkers reflecting the fibrotic process have been discovered. We performed microarray analyses between FACS-sorted steady-state fibroblasts (lineage (CD45, TER-119, CD324, CD31, LYVE-1...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2017) 131 (15): 1971–1987.
Published: 13 July 2017
... Press Limited on behalf of the Biochemical Society 2017 acute liver injury biomarker chronic liver injury liver fibrosis ischemia-reperfusion miR-223 The term ‘liver disease’ comprises various medical conditions of different underlying aetiologies (infections, metabolic conditions...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2017) 131 (7): 553–566.
Published: 17 March 2017
...Yasbanoo Moayedi; Heather J. Ross The purpose of this review is to provide an overview of diagnosis, prognosis and management of heart failure (HF) with reduced ejection fraction (HFrEF). Specifically, this review is divided into three sections. The first section will address biomarkers...
Articles
Clin Sci (Lond) (2015) 129 (1): 1–25.
Published: 01 April 2015
...Karl-Heinz Wagner; Marlies Wallner; Christine Mölzer; Silvia Gazzin; Andrew Cameron Bulmer; Claudio Tiribelli; Libor Vitek Bilirubin, the principal tetrapyrrole, bile pigment and catabolite of haem, is an emerging biomarker of disease resistance, which may be related to several recently documented...
Articles
Clin Sci (Lond) (2015) 128 (8): 449–464.
Published: 23 December 2014
... presentation and outcome, thereby highlighting the need for new predictive biomarkers. In this sense, several studies have recently revealed a role for type I IFNs (interferons), mainly IFNα, in the pathogenesis of a subset of RA patients. Genetic variants associated with the type I IFN pathway have been...
Articles
Clin Sci (Lond) (2014) 127 (5): 341–350.
Published: 15 May 2014
... (Crohn's disease) that may mandate surgical resection. Accurate biomarkers that reflect the relative contribution of fibrosis to an individual stricture are an unmet need in managing patients with CD. The miRNA-29 ( miR-29 ) family has been implicated in cardiac, hepatic and pulmonary fibrosis...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2014) 127 (4): 209–216.
Published: 10 April 2014
... some of the underlying mechanisms of OSA. The section on diabetes discusses current evidence in both humans and animal models demonstrating that intermittent hypoxia and sleep fragmentation has a negative impact on glucose tolerance. Finally, the section on cardiovascular biomarkers reviews...
Articles
Clin Sci (Lond) (2014) 127 (3): 149–161.
Published: 03 April 2014
... sequentially to the innate immune response evoked by MI. Emerging evidence on the role of MIF in myocardial ischaemia and infarction highlights a significant potential for the clinical use of MIF agonists or antagonists and as a unique cardiac biomarker. 1 These authors contributed equally...
Articles
Clin Sci (Lond) (2014) 127 (2): 77–89.
Published: 17 March 2014
...Amutha Selvamani; Madison H. Williams; Rajesh C. Miranda; Farida Sohrabji Small non-coding RNA [miRNA (microRNA)] found in the circulation have been used successfully as biomarkers and mechanistic targets for chronic and acute disease. The present study investigated the impact of age and sex...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2014) 126 (6): 377–400.
Published: 15 November 2013
...Hardip Sandhu; Helen Maddock Development of reliable biomarkers for early clinical assessment of drug-induced cardiotoxicity could allow the detection of subclinical cardiac injury risk in vulnerable patients before irreversible damage occurs. Currently, it is difficult to predict who will develop...
Articles
Clin Sci (Lond) (2014) 126 (2): 95–110.
Published: 13 September 2013
... of disease, thus improving management of diabetes and its associated complications. Not only are miRNAs displaying promise as an early biomarker for disease, but a number of these miRNAs are displaying therapeutic potential with several in pre-clinical development. The present review aims to highlight our...
Articles
Clin Sci (Lond) (2013) 124 (7): 423–441.
Published: 07 December 2012
... among others. Accordingly, they have been considered biomarkers of vascular injury and pro-thrombotic or pro-inflammatory conditions. In addition to this, emerging evidence suggests that microparticles are not simply a consequence of disease, but that they themselves may contribute to pathological...
Articles
Clin Sci (Lond) (2013) 124 (6): 389–390.
Published: 27 November 2012
... practice. Finally, the selection of the type of body fluid for biomarker discovery needs attention. Changes observed in body fluids are most reliable to the diseases of organs that are closely related to such biofluids (e.g. urine for kidney diseases, pleural fluid for lung diseases, cerebrospinal fluid...
Articles
Clin Sci (Lond) (2013) 124 (5): 289–306.
Published: 12 November 2012
... and lipid complement respectively, of a given system. Their application to ischaemic heart disease has demonstrated utilities in population profiling, identification of multivariate biomarkers and in monitoring of therapeutic response, as well as in basic mechanistic studies. Although advances in magnetic...
Articles
Clin Sci (Lond) (2011) 121 (2): 79–89.
Published: 04 April 2011
..., plasma biomarkers have emerged as a potentially alternative or complementary technique [ 4 ]. 22 11 2010 9 2 2011 10 2 2011 10 2 2011 © The Authors Journal compilation © 2011 Biochemical Society 2011 biomarker copeptin Global Registry of Acute Coronary Events (GRACE...
Articles
Clin Sci (Lond) (2011) 120 (5): 183–193.
Published: 19 November 2010
...Junhao Gui; Yaping Tian; Xinyu Wen; Wenhui Zhang; Pengjun Zhang; Jing Gao; Wei Run; Liyuan Tian; Xingwang Jia; Yanhong Gao Circulating miRNAs (microRNAs) are emerging as promising biomarkers for several pathological conditions, and the aim of this study was to investigate the feasibility of using...
Includes: Supplementary data
Articles
Clin Sci (Lond) (2011) 120 (2): 81–89.
Published: 08 October 2010
... evidence suggests that sRAGE may be a potential biomarker of RAGE-mediated pathology. The present study aimed to examine the relationship between RAGE expression in peripheral blood monocytes and circulating sRAGE and esRAGE (endogenous sRAGE, a splice variant of sRAGE) in Type 2 diabetes. Protein...
Articles
Clin Sci (Lond) (2011) 120 (2): 51–63.
Published: 24 September 2010
... diseases. The revisited concept of a potential use of endogenous EPO levels as a predictor of CHF severity, as well as in the monitoring of responses to treatment, deserves appropriate investigation, as this may identify EPO as a useful biomarker in the clinical management of cardiovascular diseases...
Articles
Clin Sci (Lond) (2010) 119 (5): 203–205.
Published: 02 June 2010
... and available, specific treatment. Correspondence: Professor Aldo Clerico (email clerico@ifc.cnr.it ). 29 4 2010 4 5 2010 4 5 2010 © The Authors Journal compilation © 2010 Biochemical Society 2010 biomarker cardiac troponin T (cTnT) echocardiography high-sensitive cardiac...
Articles
Clin Sci (Lond) (2010) 119 (5): 207–213.
Published: 02 June 2010
... (N-terminal pro-brain natriuretic protein). Moreover, hsTnT predicted a WHO (World Health Organization) functional class >II better than NT-proBNP or hFABP. In conclusion, in PAH patients, the novel biomarker hsTnT is associated with death and advanced WHO functional class, and is related...
Articles
Clin Sci (Lond) (2010) 119 (2): 87–95.
Published: 20 April 2010
..., the levels of circulating cell-free miR-1 were significantly increased in patients with AMI and had a positive correlation with serum CK-MB (creatine kinase-MB) levels. In conclusion, the results suggest that serum miR-1 could be a novel sensitive diagnostic biomarker for AMI. 1 These authors...
Articles
Clin Sci (Lond) (2010) 118 (12): 717–725.
Published: 30 March 2010
... need to develop biomarkers for earlier detection of ovarian cancer. In the present study, we demonstrate for the first time that the previously reported metastasis-inducing protein AGR2 (anterior gradient protein 2) can be detected in the blood of ovarian cancer patients. Using a newly developed ELISA...
Articles
Clin Sci (Lond) (2008) 114 (11): 661–677.
Published: 01 May 2008
... signalling pathways and control of the vessel wall matrix will be as important as those involved in the renin–angiotensin system, adrenergic and other vasoactive systems. Identifying the genes involved is important, since it may suggest new biomarkers as well as provide novel drug targets to reduce arterial...
Articles
Clin Sci (Lond) (2005) 109 (5): 421–430.
Published: 24 October 2005
..., a major priority is the identification of disease-associated biomarkers. Proteomics, with its high-throughput and unbiased approach to the analysis of variations in protein expression patterns (actual phenotypic expression of genetic variation), promises to be the most suitable platform for biomarker...